Maintenance and Rarefaction of the Native Collateral Circulation

原生侧支循环的维持和稀疏

基本信息

  • 批准号:
    8876770
  • 负责人:
  • 金额:
    $ 46.8万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-09-26 至 2016-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Occlusive vascular disease of the heart, brain and peripheral limbs is the primary cause of morbidity and mortality in the US. Native (pre-existing) collaterals (COLs) interconnect adjacent arterial trees and function critically as bypass vessels i vascular obstruction occurs. Over the past 25 years investigators have focused on mechanisms mediating outward remodeling of COLs in ischemic disease. However, until our work nothing was known about what controls the number and diameter (extent) of these unique vessels in healthy tissue. We have shown that COL extent in murine brain and hindlimb varies widely due to genetic polymorphisms. Moreover, variation in extent has a greater impact on the severity of ischemic tissue injury than does variation in remodeling. Our findings have thus focused attention on the importance of under-standing the genetic mechanisms controlling extent of the native COL circulation. A major goal of the present proposal is to determine if environmental factors, ie, cardiovascular risk factors and disease (CVRFs), also adversely affect COL extent. While observations in patients suggest this could be true, our preliminary studies in mice strongly support this novel hypothesis: Aging causes an age-dose-dependent decline in COL density and diameter (rarefaction) that mechanistically links to endothelial cell/eNOS dysfunction (ECdys)-thus identifying eNOS- NO as an essential maintenance factor for COLs. In other preliminary studies we have found that COLs have remarkable structural and functional specializations, compared to arterioles in the general circulation, e.g., a flow-oriented EC alignment, abundant primary cilia (PRC), increased basal proliferation, and a unique gene expression profile. We hypothesize that this novel COL phenotype reflects the disturbed shear stress (DSS) environment in which COLs reside and is essential for their persistence. Furthermore, we postulate that this DSS environment causes accelerated proliferative EC senescence, and thus high susceptibility of COLs to premature rarefaction by CVRFs. Aim I will determine if genetic mouse models of CVRFs cause COL rarefac- tion in brain and hindlimb, leading to more severe ischemic tissue injury. AIM II will test the hypothesis that COL ECs express a unique phenotype, important for their persistence in a DSS environment and sensitivity to rarefaction by CVRFs, using in-depth cellular and molecular analyses, and conditional cell-specific gene targeting. Aim III will seek to prevent or arrest COL rarefaction in CVRF models using therapies that target EC/eNOS-dysfunction and vascular inflammation that are already in use patients or in clinical trials for other indications. Successful outcome of thes studies will define a new risk factor for ischemic disease-severity, ie, COL rarefaction, and therapeutic approaches to prevent it, and identify a novel structural/gene expression phenotype or marker that distinguishes collaterals from other vessels and which is essential for their persistence and function.
描述(由申请人提供):心脏、大脑和周围四肢的闭塞性血管疾病是美国发病和死亡的主要原因。天然(预先存在的)侧支(COL)将相邻的动脉树相互连接,并在血管阻塞发生时在旁路血管中发挥关键作用。在过去的 25 年里,研究人员一直关注缺血性疾病中 COL 向外重塑的介导机制。然而,在我们的工作之前,我们对健康组织中这些独特血管的数量和直径(范围)的控制因素一无所知。我们已经表明,由于遗传多态性,小鼠大脑和后肢的 COL 程度差异很大。此外,程度的变化对缺血性组织损伤的严重程度的影响比重塑的变化更大。因此,我们的研究结果将注意力集中在了解控制天然 COL 循环程度的遗传机制的重要性上。本提案的主要目标是确定环境因素(即心血管危险因素和疾病 (CVRF))是否也会对 COL 程度产生不利影响。虽然对患者的观察结果表明这可能是正确的,但我们对小鼠的初步研究有力地支持了这一新假设:衰老导致 COL 密度和直径呈年龄剂量依赖性下降(稀疏),这在机制上与内皮细胞/eNOS 功能障碍 (ECdys) 相关,从而确定 eNOS-NO 是 COL 的重要维持因子。在其他初步研究中,我们发现与大循环中的小动脉相比,COL 具有显着的结构和功能特化,例如,流向的 EC 排列、丰富的初级纤毛 (PRC)、增加的基底增殖和独特的基因表达谱。我们假设这种新的 COL 表型反映了 COL 所处的扰动剪切应力 (DSS) 环境,并且对于它们的持久性至关重要。此外,我们假设这种 DSS 环境会导致 EC 加速增殖衰老,因此 COL 对 CVRF 过早稀疏的敏感性很高。目的 我将确定 CVRF 的遗传小鼠模型是否会导致大脑和后肢 COL 稀疏,从而导致更严重的缺血性组织损伤。 AIM II 将使用深入的细胞和分子分析以及条件细胞特异性基因靶向来测试 COL EC 表达独特表型的假设,这对于它们在 DSS 环境中的持久性和对 CVRF 稀疏的敏感性非常重要。目标 III 将寻求防止或阻止 COL 稀疏化 CVRF 模型使用针对 EC/eNOS 功能障碍和血管炎症的疗法,这些疗法已在患者中使用或处于其他适应症的临床试验中。这些研究的成功结果将定义缺血性疾病严重程度的新危险因素,即 COL 稀疏,以及预防它的治疗方法,并确定一种新的结构/基因表达表型或标记,以区分络脉与其他血管,这对于络脉的持久性和功能至关重要。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Sex Differences in the Cerebral Collateral Circulation.
  • DOI:
    10.1007/s12975-016-0508-0
  • 发表时间:
    2017-06
  • 期刊:
  • 影响因子:
    6.9
  • 作者:
    Faber JE;Moore SM;Lucitti JL;Aghajanian A;Zhang H
  • 通讯作者:
    Zhang H
Leptomeningeal collaterals are associated with modifiable metabolic risk factors.
  • DOI:
    10.1002/ana.23906
  • 发表时间:
    2013-08
  • 期刊:
  • 影响因子:
    11.2
  • 作者:
    Menon, Bijoy K.;Smith, Eric E.;Coutts, Shelagh B.;Welsh, Donald G.;Faber, James E.;Goyal, Mayank;Hill, Michael D.;Demchuk, Andrew M.;Damani, Zaheed;Cho, Kyung-Hee;Chang, Hyuk-Won;Hong, Jeong-Ho;Sohn, Sung Il
  • 通讯作者:
    Sohn, Sung Il
De-novo collateral formation following acute myocardial infarction: Dependence on CCR2⁺ bone marrow cells.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JAMES E FABER其他文献

JAMES E FABER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JAMES E FABER', 18)}}的其他基金

Targeting the Pial Collateral Circulation for Mitigation of Cerebral Ischemia
针对软脑膜侧支循环缓解脑缺血
  • 批准号:
    9896889
  • 财政年份:
    2013
  • 资助金额:
    $ 46.8万
  • 项目类别:
Targeting the Pial Collateral Circulation for Mitigation of Cerebral Ischemia
针对软脑膜侧支循环缓解脑缺血
  • 批准号:
    8662826
  • 财政年份:
    2013
  • 资助金额:
    $ 46.8万
  • 项目类别:
Targeting the Pial Collateral Circulation for Mitigation of Cerebral Ischemia
针对软脑膜侧支循环缓解脑缺血
  • 批准号:
    8558449
  • 财政年份:
    2013
  • 资助金额:
    $ 46.8万
  • 项目类别:
Maintenance and Rarefaction of the Native Collateral Circulation
原生侧支循环的维持和稀疏
  • 批准号:
    8551687
  • 财政年份:
    2012
  • 资助金额:
    $ 46.8万
  • 项目类别:
Maintenance and Rarefaction of the Native Collateral Circulation
原生侧支循环的维持和稀疏
  • 批准号:
    8699824
  • 财政年份:
    2012
  • 资助金额:
    $ 46.8万
  • 项目类别:
Maintenance and Rarefaction of the Native Collateral Circulation
原生侧支循环的维持和稀疏
  • 批准号:
    8366973
  • 财政年份:
    2012
  • 资助金额:
    $ 46.8万
  • 项目类别:
Mechanisms of Collateral Development and Collateral Growth in Ischemia
缺血时的侧枝发育和侧枝生长机制
  • 批准号:
    7910685
  • 财政年份:
    2008
  • 资助金额:
    $ 46.8万
  • 项目类别:
Mechanisms of Collateral Development and Collateral Growth in Ischemia
缺血时的侧枝发育和侧枝生长机制
  • 批准号:
    7655324
  • 财政年份:
    2008
  • 资助金额:
    $ 46.8万
  • 项目类别:
Mechanisms of Collateral Development and Collateral Growth in Ischemia
缺血时的侧枝发育和侧枝生长机制
  • 批准号:
    8130993
  • 财政年份:
    2008
  • 资助金额:
    $ 46.8万
  • 项目类别:
CORE--HISTOLOGY CORE
核心--组织学核心
  • 批准号:
    6828189
  • 财政年份:
    2004
  • 资助金额:
    $ 46.8万
  • 项目类别:

相似国自然基金

靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0 万元
  • 项目类别:
    面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
  • 批准号:
    2023JJ50274
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    33 万元
  • 项目类别:
    地区科学基金项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
  • 批准号:
    n/a
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
  • 批准号:
    81973577
  • 批准年份:
    2019
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
  • 批准号:
    81602908
  • 批准年份:
    2016
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
  • 批准号:
    81501928
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
  • 批准号:
    23K07844
  • 财政年份:
    2023
  • 资助金额:
    $ 46.8万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
  • 批准号:
    22KJ2960
  • 财政年份:
    2023
  • 资助金额:
    $ 46.8万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
  • 批准号:
    23KK0156
  • 财政年份:
    2023
  • 资助金额:
    $ 46.8万
  • 项目类别:
    Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
  • 批准号:
    10677409
  • 财政年份:
    2023
  • 资助金额:
    $ 46.8万
  • 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
  • 批准号:
    497927
  • 财政年份:
    2023
  • 资助金额:
    $ 46.8万
  • 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
  • 批准号:
    10836835
  • 财政年份:
    2023
  • 资助金额:
    $ 46.8万
  • 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
  • 批准号:
    10679287
  • 财政年份:
    2023
  • 资助金额:
    $ 46.8万
  • 项目类别:
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
  • 批准号:
    478877
  • 财政年份:
    2023
  • 资助金额:
    $ 46.8万
  • 项目类别:
    Operating Grants
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
  • 批准号:
    23K06378
  • 财政年份:
    2023
  • 资助金额:
    $ 46.8万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
  • 批准号:
    23K10845
  • 财政年份:
    2023
  • 资助金额:
    $ 46.8万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了